Pharmacokinetic aspects of palinavir, an HIV protease inhibitor, in Sprague-Dawley rats.
Liard
F
F
Department of Biological Sciences, Bio-Méga division recherche Boehringer Ingelheim (Canada) Ltée, 2100, rue Cunard, Laval, Qué., Canada, H7S 2G5.
Jaramillo
J
J
Paris
W L
WL
Yoakim
C
C
D000818:Animals; D019380:Anti-HIV Agents / Q000493:pharmacokinetics*; D001682:Biological Availability; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics*; D011804:Quinolines / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014633:Valine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011804:Quinolines; C107199:palinavir; D014633:Valine